← All companies
OM
Outset Medical, Inc.
$4.99
+0.24 +5.05%
Key statistics
from XBRL data in SEC filingsMarket cap
$92.5M
Revenue (TTM)
$118M
Net income (TTM)
-$74.8M
EPS (TTM)
$-2.74
P/E ratio
—
Dividend yield
—
Free cash flow
-$47.1M
Cash
$30.6M
Total assets
$249M
Gross margin
40.6%
52-week range
$3.00 – $17.20
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Results of operations (earnings release)
Jun 17, 2026
8-K
Shareholder vote results
Jun 5, 2026
8-K
Director or officer change
May 29, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Results of operations (earnings release)
May 7, 2026
10-K
Fiscal year ended 2025-12-31
Feb 13, 2026
8-K
Results of operations (earnings release)
Feb 11, 2026
8-K
Other events
Jan 27, 2026
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 6, 2025
8-K
Director or officer change; Shareholder vote results; Regulation FD disclosure
Jun 3, 2025
8-K
Director or officer change; Regulation FD disclosure
May 14, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 7, 2025
8-K
Modified rights of security holders; Amended charter or bylaws
Mar 20, 2025
8-K
Other events
Mar 18, 2025
8-K
Amended charter or bylaws; Other events
Mar 11, 2025
8-K
Shareholder vote results
Mar 6, 2025
10-K
Fiscal year ended 2024-12-31
Feb 28, 2025
8-K
Delisting notice or listing-rule failure; Other events
Feb 26, 2025
8-K
Results of operations (earnings release)
Feb 19, 2025
8-K
Amended charter or bylaws
Jan 24, 2025
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Amended charter or bylaws
Jan 8, 2025
8-K
Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure
Jan 6, 2025
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 6, 2024
8-K
Delisting notice or listing-rule failure
Sep 27, 2024
8-K
Director or officer change
Aug 16, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 7, 2024
8-K
Shareholder vote results
May 30, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release); Director or officer change; Other events
May 8, 2024
8-K
Other events
May 6, 2024
8-K
Director or officer change; Regulation FD disclosure
Mar 13, 2024
10-K
Fiscal year ended 2023-12-31
Feb 21, 2024
8-K
Results of operations (earnings release); Director or officer change
Feb 21, 2024